Levodopa nanoencapsulation in nanostarch as anti-parkinsonian drugs candidate
Parkinson's disease is caused by damage to the dopaminergic nerves in brain. Levodopa has been widely used to treat Parkinson's disease. The levodopa nano encapsulation aims to improve drug-delivery efficiency thereby increasing the concentration of released levodopa in the brain. This stu...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | en |
| Published: |
Scientific Publishers
2023
|
| Subjects: | |
| Online Access: | http://umpir.ump.edu.my/id/eprint/44265/1/Levodopa%20nanoencapsulation%20in%20nanostarch%20as%20anti-parkinsonian.pdf http://umpir.ump.edu.my/id/eprint/44265/ https://doi.org/10.56042/ijc.v62i10.6184 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
